These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions. Sanders S; Geraci SA J Miss State Med Assoc; 2010 Mar; 51(3):75-80. PubMed ID: 20827876 [TBL] [Abstract][Full Text] [Related]
7. Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis? Kaplan MJ Nat Clin Pract Rheumatol; 2005 Dec; 1(2):74-5. PubMed ID: 16932633 [No Abstract] [Full Text] [Related]
8. TNF antagonist safety in rheumatoid arthritis: updated evidence from observational registries. Nasir A; Greenberg JD Bull NYU Hosp Jt Dis; 2007; 65(3):178-81. PubMed ID: 17922666 [TBL] [Abstract][Full Text] [Related]
9. Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis. Giles JT; Post W; Blumenthal RS; Bathon JM Nat Clin Pract Rheumatol; 2006 Jun; 2(6):320-9. PubMed ID: 16932711 [TBL] [Abstract][Full Text] [Related]
10. Developments in rheumatoid arthritis. Thomas J; Scott D Practitioner; 2006 Jun; 250(1683):31, 33, 35 passim. PubMed ID: 16856503 [No Abstract] [Full Text] [Related]
11. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk factors, fitness and physical activity in rheumatic diseases. Turesson C; Matteson EL Curr Opin Rheumatol; 2007 Mar; 19(2):190-6. PubMed ID: 17278937 [TBL] [Abstract][Full Text] [Related]
13. Which are the determinants of dyslipidemia in rheumatoid arthritis and does socioeconomic status matter in this context? Dessein PH; Christian BF; Solomon A J Rheumatol; 2009 Jul; 36(7):1357-61. PubMed ID: 19567631 [No Abstract] [Full Text] [Related]
14. Heightened risk of cardiovascular disease in patients with rheumatoid arthritis, heightened risk of cardiovascular disease in patients with rheumatoid arthritis. Introduction. Pearson TA Am J Med; 2008 Oct; 121(10 Suppl 1):S1-2. PubMed ID: 18926164 [No Abstract] [Full Text] [Related]
15. Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. Cleland LG; Caughey GE; James MJ; Proudman SM J Rheumatol; 2006 Oct; 33(10):1973-9. PubMed ID: 16881100 [TBL] [Abstract][Full Text] [Related]
17. [Chronic inflammation increases the risk of cardiovascular disease in patients with rheumatoid arthritis]. Troelsen LN; Jacobsen S Ugeskr Laeger; 2006 Sep; 168(39):3304-8. PubMed ID: 17032593 [TBL] [Abstract][Full Text] [Related]
18. Corticosteroids in the management of early and established rheumatoid disease. Morrison E; Capell HA Rheumatology (Oxford); 2006 Sep; 45(9):1058-61. PubMed ID: 16880186 [No Abstract] [Full Text] [Related]
19. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs. Avouac J; Allanore Y Expert Opin Pharmacother; 2008 May; 9(7):1121-8. PubMed ID: 18422470 [TBL] [Abstract][Full Text] [Related]
20. Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. Metsios GS; Stavropoulos-Kalinoglou A; Panoulas VF; Wilson M; Nevill AM; Koutedakis Y; Kitas GD Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):188-94. PubMed ID: 19238083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]